TrialMedicine2019

Plasma miR-32 levels in non-small cell lung cancer patients receiving platinum-based chemotherapy can predict the effectiveness and prognosis of chemotherapy.

Shuyuan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.